Navigation Links
Cancer-causing Property Of Teflon Leaves US Regulators Concerned

Regulators in the United States are worried about the cancer causing potential of perfluorooctanoic acid, or PFOA, which is widely used in making Teflon or non-stick cookware. // The concern was triggered off after an independent review by a committee for the Environmental Protection Agency said that Teflon had likely cancer causing potential.

"The predominant panel view was that the descriptor 'likely to be carcinogenic' was more consistent with currently available data, while a few panel members reached the conclusion that the current evidence fails to exceed the descriptor 'suggestive,' of carcinogenicity," the panel had said in its report. The EPA's Science Advisory Board, which had asked for a review said that the finding was on expected lines. However, DuPont, which is the only manufacturer of Teflon in North America has been releasing ads asserting the safety of their product, "We disagree with the panel's recommendation on the cancer classification, and we continue to support the EPA's draft risk assessment," said Robert Rickard, DuPont’s director of health and environmental sciences. "This reflects recommended classification; what's more important is risk, and we are confident that PFOA does not pose a cancer risk to the general public." It is reported that PFOA can cause breast cancer, testicular cancer and colon cancer.


'"/>




Page: 1

Related medicine news :

1. Fruits And Vegetables Have Arthritis Risk Reducing Property
2. Opposition against Amendments in the Intellectual Property Law
3. Warfarin’s Anti-clotting Property May Cause Hemorrhagic Stroke
4. Will Teflon Regain Its Rightful Place In The Kitchen?
5. Teflon not toxic after all says reports
6. Strange Theft Of HIV Infected Blood Leaves Authorities Puzzled
7. Mass Leave By Doctors Leaves Patients Helpless
8. Anti Inflammatory Evaluation Of Plumeria Acuminata Leaves
9. Einsteins Tea Leaves Inspire New Blood Separation Technique
10. United Kingdom: Maternity Units Exposed! Leaves Much to Be Desired
11. A brush with the U.S. Regulators can cost a fortune
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, the game-changing dual ... opening of the Sober College Robert Pfeifer Memorial Learning Center at its location ... was attended by an overwhelming amount of alumni, family, colleagues and friends of ...
(Date:12/9/2016)... ... ... "I had a terrible time trying to get my grandson to use his ... had a more child-friendly design, then children would be more likely to look forward ... avoid the need to deliver medication via a nebulizer mask. The design will not ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Company LLC, announced the first national #QuackGivesBack campaign which supported local breast ... was our first franchise-wide Quack Gives Back initiative, and we’re very ...
(Date:12/8/2016)... ... 08, 2016 , ... With the increasing demand for dental implants, the National ... campaign to inform dentists and patients about the safety issues related to dental restorations. ... in the U.S. is projected to reach $6.4 billion in 2018 with more than ...
(Date:12/8/2016)... N.J. (PRWEB) , ... December 08, 2016 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, today ... PSCI was set up in 2006 as a non-profit organization to unite pharmaceutical ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016 Allergy Diagnostics Market: Scope and ... that are used to determine the presence of ... drugs etc. in the samples by determining the ... The report on global allergy diagnostics market, analyzes ... The report consists of an executive summary that ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Dec. 8, 2016  Valeant Pharmaceuticals International, Inc. ... ("Valeant") today announced positive results from a Phase ... assess the safety and efficacy of IDP-118 (halobetasol ... plaque psoriasis. Within the Phase ... to severe psoriasis, IDP-118 showed statistical significance to ...
Breaking Medicine Technology: